DFC 004 Biomarkers for Active Diabetic Foot Ulcers

Part of paid clinical trials in Tucson, Arizona.

Sponsor
University of Michigan
Study ID
NCT06104969
Status
Recruiting

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Study Details

This study is a platform study designed to efficiently test multiple biomarkers to identify diabetic foot ulcers (DFUs) with a higher potential for healing versus not healing that ultimately could be applied at the point of care to drive personalized management decisions, and to better inform clinical trials of wound healing interventions

Key Dates

Start date
Jun 15, 2023
Status verified
Sep 2025
Primary completion
Jun 15, 2028
Completion
Jun 15, 2028

Study Design

Enrollment
5,000 participants (estimated)

Arms

  • Arm: Diabetic Foot Ulcer
    Adult individuals with at least one diabetic foot ulcer who meet inclusion/exclusion criteria

Primary Outcome Measure

Wound Healing [ Time Frame: 52 Weeks ]

Locations (8)

FacilityCityStateZIPSite coordinators
University of Arizona College of MedicineTucsonArizona85724
Fleur Maturo
520-621-8296
Geoffrey Gurtner, MD (PRINCIPAL_INVESTIGATOR)
University of Southern CaliforniaLos AngelesCalifornia90033-
University of California - San FranciscoSan FranciscoCalifornia94143
Claudio Gamboa
415-353-4379
Michael Conte, MD (PRINCIPAL_INVESTIGATOR)
Emory University School of MedicineAtlantaGeorgia30303
Nazanin Soleimanmanesh
404-251-2599
Marcos Schechter (PRINCIPAL_INVESTIGATOR)
Maya Fayfman (PRINCIPAL_INVESTIGATOR)
Beth Israel Deaconess Medical CenterBostonMassachusetts02215
Jessica Gilman
617-632-8429
Aristidis Veves, MD (PRINCIPAL_INVESTIGATOR)
University of MichiganAnn ArborMichigan48109
Kourtney Noll
734-763-0177
Crystal Holmes, DPM (PRINCIPAL_INVESTIGATOR)
Northwell HealthLake SuccessNew York11042
Amit Rao
516-233-3671
Alisha Oropallo, MD (PRINCIPAL_INVESTIGATOR)
University of PittsburghPittsburghPennsylvania15219
Shomita Steiner
463-237-8770
Chanden Sen, PhD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Tucson, AZ

Related Studies